Durvalumab maintenance therapy with a possible abscopal effect after stereotactic brain radiotherapy in extensive-small cell lung cancer: a case report
Case Reports in Oncology · 10.11.2026
DOI: 10.1159/cro/abzag098 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Oncology, online erschienen am 10.11.2026. Verfasst von Atsuhisa Yoshino und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The abscopal effect refers to regression of tumors outside the irradiated field following local radiotherapy and is thought to be mediated by systemic immune activation. Reports of this phenomenon have increased in the era of immune checkpoint inhibitors (ICIs), particularly in non-small cell lung cancer. However, it remains extremely rare in small cell lung cancer (SCLC). Case Presentation: We report the case of a 77-year-old man with extensive-stage SCLC (cT2aN2bM1a, Stage IVA). He received carboplatin, etoposide, and durvalumab followed by maintenance durvalumab. On Day 533, a solitary 10-mm brain metastasis developed, accompanied by a mild enlargement of the primary lung tumor to 30 mm. In contrast, hilar and mediastinal lymph node metastases had decreased in size, and contralateral pleural dissemination remained stable. Stereotactic brain radiotherapy (27 Gy in three fractions) was administered while durvalumab maintenance therapy was continued. By Day 605, follow-up CT revealed complete regression of the non-irradiated primary lung tumor (from 30 to 0 mm), with ongoing control of nodal disease and stable pleural dissemination. Disease control has been sustained for more than 1,277 days since treatment initiation.
Conclusion
We report a rare case of a possible abscopal effect observed following stereotactic radiotherapy during durvalumab maintenance therapy for extensive-stage SCLC.
Zitieren
APA
Yoshino, A., Wakabayashi, H., Akiyama, N., Iwayanagi, M., Namba, K., Ohashi, R., Sakurai, H., Takashima, K., Murakami, Y., & Isobe, K. (2026). Durvalumab maintenance therapy with a possible abscopal effect after stereotactic brain radiotherapy in extensive-small cell lung cancer: a case report. Case Reports in Oncology. https://doi.org/10.1159/cro/abzag098
Vancouver
Yoshino A, Wakabayashi H, Akiyama N, Iwayanagi M, Namba K, Ohashi R, et al. Durvalumab maintenance therapy with a possible abscopal effect after stereotactic brain radiotherapy in extensive-small cell lung cancer: a case report. Case Reports in Oncology. 2026. doi:10.1159/cro/abzag098
BibTeX
@article{Yoshino2026,
author = {Yoshino, Atsuhisa and Wakabayashi, Hiroki and Akiyama, Nanako and Iwayanagi, Misa and Namba, Kensuke and Ohashi, Ryogo and Sakurai, Hiromasa and Takashima, Kenta and Murakami, Yu and Isobe, Kazutoshi},
title = {Durvalumab maintenance therapy with a possible abscopal effect after stereotactic brain radiotherapy in extensive-small cell lung cancer: a case report},
journal = {Case Reports in Oncology},
year = {2026},
doi = {10.1159/cro/abzag098}
}
EUVIMED